ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

Sun Pharma Advanced Research Company Limited Complete list of announcements declared & dividend announcements by Sun Pharma Advanced Research Company Limited SPARC

Sun Pharma Advanced Research Company Limited SPARC listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Sun Pharma Advanced Research Company Limited SPARC

Sun Pharmaceuticals to acquire Checkpoint Therapeutics for 5 mn
Sun Pharmaceuticals will acquire Checkpoint Therapeutics for 5 million, bringing the FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma, UNLOXCYT, to a broader market. The acquisition enhances Sun Pharma's oncology portfoli
Announcement as on 10 March 2025

Sun Pharma, Indian Hotels among 5 stocks with short covering
Short covering lifted five stocks on March 7, with open interest declining. IEX, Lupin, Bharat Forge, Indian Hotels, and Sun Pharma saw marginal price gains as traders exited short positions.
Announcement as on 07 March 2025

Company Announcement
Sun Pharma Advanced Research Company Limited has informed the Exchange about Credit Rating- Revision
Announcement as on 06 March 2025

Sun Pharma aims to launch anti-obesity and type 2 diabetes drug Utreglutide in five years: Dilip Shanghvi
Sun Pharmaceutical, India's largest drugmaker by revenue, plans to launch its experimental anti-obesity and type 2 diabetes drug Utreglutide in the next four to five years, said Managing Director Dilip Shanghvi. The drug is a GLP-1 receptor agonist and has
Announcement as on 03 March 2025

Sumit Gupta remains positive on Cipla and Sun Pharma amid strong US generic market performance
So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the niche launches. And if you see, the commentary has also been very positive. They have revised the guidance to upwards of 25.5%, which t
Announcement as on 18 February 2025

Announcements by Sun Pharma Advanced Research Company Limited first page | Next page | Prev page |

SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals

Moving Averages for Sun Pharma Advanced Research Company Limited

  • 5Day Average: 191.34
  • 12Day Average: 197.08
  • 20Day Average: 197.22
  • 50Day Average: 209.3
  • 100Day Average: 207.87
  • 150Day Average: 181.92
  • 200Day Average: 170.42

SPARC Indicators & signals

Indicator MACD (12,26,9)

195.31, 199.39, -3.97
Indicator MACD is in negative zone

Indicator ADX (14)

2.5, 18.86, 19.83
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Fri Sep 2026 193.92 192.39 to 198.60 0.39% 0.9 times
17 Thu Sep 2026 193.16 183.08 to 195.36 4.08% 1.1 times
16 Wed Sep 2026 185.59 182.00 to 190.81 -1.28% 0.89 times
15 Tue Sep 2026 188.00 186.99 to 198.09 -4.09% 0.83 times
11 Fri Sep 2026 196.01 192.56 to 197.55 -0.46% 0.63 times
10 Thu Sep 2026 196.91 196.25 to 204.60 -1.83% 0.92 times
09 Wed Sep 2026 200.58 200.07 to 204.00 -1.32% 0.68 times
08 Tue Sep 2026 203.27 201.25 to 206.96 -1.26% 0.83 times
07 Mon Sep 2026 205.87 199.59 to 208.65 3.21% 1.97 times
04 Fri Sep 2026 199.47 199.00 to 203.19 -1.52% 0.77 times
03 Thu Sep 2026 202.54 198.50 to 205.90 1.48% 1.38 times
02 Wed Sep 2026 199.58 194.77 to 207.80 1.32% 3.17 times

Videos related to: SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

 

Back to top